Nanosecond pulsed electric field ablation as first-line curative therapy for hepatocellular carcinoma in high-risk locations a prospective multicenter
To our knowledge, this was the first prospective trial demonstrating that nsPEF was effective and relatively safe for HCC in high-risk locations, and may serve as an alternative therapeutic option for HCC suboptimal for thermal ablation.
Authors
- Zhigang Ren (ORCID: https://orcid.org/0000-0003-0798-3444)
- Jinhua Pan (ORCID: https://orcid.org/0000-0002-6691-8282)
- Qiyu Zhao (ORCID: https://orcid.org/0000-0002-8732-8564)
- Gang Dong
- Tianan Jiang (ORCID: https://orcid.org/0000-0002-7672-8394)
- Tuerganaili Aji (ORCID: https://orcid.org/0000-0001-6737-8874)
- Wu Zhang (ORCID: https://orcid.org/0000-0002-7887-8345)
- Xinhua Chen (ORCID: https://orcid.org/0000-0002-4573-9111)
- Min Xu (ORCID: https://orcid.org/0000-0001-9455-9494)
- Danxia Xu
- Jiansong Ji (ORCID: https://orcid.org/0000-0003-4727-2794)
Institutions
- Xinjiang Medical University (CN)
- First Affiliated Hospital of Xinjiang Medical University (CN)
- Lishui Central Hospital (CN)
- Zhejiang Shuren University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1097/js9.0000000000002361
- Citations
- 8
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 10.58